Tag: dermatology
Alphyn Biologics Begins Phase 2b Trial for Zabalafin Hydrogel.
Introduction.
Alphyn Biologics has officially dosed the first patient in its Phase 2b trial for Zabalafin Hydrogel. This drug is...
Journey Medical Corporation Showcased Emrosi™ at 2025 American Academy of Dermatology Annual Meeting.
Journey Medical Corporation (Nasdaq: DERM) exhibited at the 2025 American Academy of Dermatology (AAD) Annual Meeting. The event was...
Sotyktu’s 5-Year Data Support Its Long-Term Efficacy for Plaque Psoriasis.
Five-year clinical results underscore the long-term efficacy and safety of Sotyktu (deucravacitinib) for plaque psoriasis, holding new promise for...
